Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections

Pediatric Infectious Disease Journal

Volumn 24, Issue 5, 2005, Pages 438-444

  Esposito, Susanna ^a   Basis, Samantha ^a   Faelli, Nadia ^a   Begliatti, Enrica ^a   Droghetti, Roberta ^a   Tremolati, Elena ^a   Porta, Alessandro ^a   Blasi, Francesco ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Atypical bacteria; Azithromycin; Chlamydia pneumoniae; Mycoplasma pneumoniae; Recurrent respiratory tract infections

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN;

ADOLESCENT; ARTICLE; ASPIRATION; BACTERIAL INFECTION; CHILD; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NASOPHARYNX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION;

ADOLESCENT; AMBULATORY CARE FACILITIES; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PROBABILITY; RECURRENCE; REFERENCE VALUES; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 18644381628     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000160949.99560.8d     Document Type: Article

References (37)

1. Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002;112(suppl 6A):4S-12S.
2. Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med. 2002;156:121-126.
3. Nokso-Koivisto J, Pitkäranta A, Blomqvist S, et al. Viral etiology of frequently recurring respiratory tract infections in children. Clin Infect Dis. 2002;35:540-546.
4. Brook O. Microbial factors leading to recurrent upper respiratory tract infections. Pediatr Infect Dis J. 1998;17:S62-S67.
5. Hopp R. Evaluation of recurrent respiratory tract infections in children. Curr Probl Pediatr. 1996;26:148-158.
6. Korppi M. Recurrent respiratory infections in children: a practical approach for clinical work. Pediatr Pulmonol. 1997;24(suppl 16):144-145.
7. Malaponte G, Bevelacqua V, Li Volti G, et al. Soluble adhesion molecules and cytokines in the children affected by recurrent infections of the upper respiratory tract. Pediatr Res. 2004;55:666-673.
8. de Vries E. Immunological investigations in children with recurrent respiratory infections. Pediatr Respir Rev. 2001;2:32-36.
9. Paul ME, Shearer WT. The child who has recurrent infections. Pediatr Allergy Immunol. 1999;19:423-436.
10. Gryczyńska D, Kobos J, Zakrzewska A. Relationship between passive smoking, recurrent respiratory tract infections and otitis media in children. Intern J Pediatr Otorhinol. 1999;49(suppl 1):S275-S278.
11. Mäkelä MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539-542.
12. Principi N, Marchisio P, Schito GC, Mannelli S, Ascanius Project Collaborative Group. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediatr Infect Dis J. 1999;18:5l7-523.
13. Henrickson KJ, Hoover S, Kehl KS, Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004;23(suppl 1):S11-S18.
14. Monto AS. Occurrence of respiratory virus: time, place and person. Pediatr Infect Dis J. 2004;23(suppl 1):S58-S64.
15. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-477.
16. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994;148:727-732.
17. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis. 2001;1:334-344.
18. Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis. 2002;15:295-300.
19. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacteria infections in children 2 to 5 years of age with community-acquired pneumonia. Clin Infect Dis. 2002;35: 1345-1352.
20. Principi N, Esposito S, Blasi F, Allegra L, Mowgli Study Group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis. 2001;32:1281-1289.
21. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998;11:345-349.
22. Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis. 2004;38:1341-1346.
23. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 2002;121:1782-1788.
24. Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, Principi N. Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis. Eur J Clin Microbiol Infect Dis. 2000;21:607-610.
25. Esposito S, Blasi F, Bosis S, et al. Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol. 2004;53:645-651.
26. Esposito S, Blasi F, Bellini F, Allegra L, Principi N, Mowgli Study Group. Characteristics of Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Eur Respir J. 2001; 17:241-245.
27. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infection in children with wheezing. Eur Respir J. 2000;16:1142-1146.
28. Principi N, Esposito S, Cavagna R, et al. Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. J Chemother. 2003;15:53-59.
29. Principi N, Esposito S. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. Drug Saf. 1999; 20:25-41.
30. Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: W. B. Saunders; 1998.
31. Nystad W, Skrondal A, Nja F, Hetlevik O, Carlsen KH, Magnus P. Recurrent respiratory tract infections during the first 3 years of life and atopy at school age. Allergy. 1998;53:1189-1194.
32. Wang SP, Grayston JT. Immunological relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol. 1970; 70:367-374.
33. Normann E, Gnarpe J, Gnarpe H, et al. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr. 1998;87: 23-27.
34. Black PN. The use of macrolides in the treatment of asthma. Eur Respir Rev. 1996;6:240-243.
35. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 1992;14:178-182.
36. Gilleran SN, Trow TK. Macrolides and lung disease: more than an antibiotic? Clin Pulm Med. 2003;10:350-352.
37. Hardy RD, Rios AK, Chavez-Bueno S, et al. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob Agents Chemother. 2003; 47:1614-1620.